Long-duration oral vancomycin to treat clostridioides difficile in patients with inflammatory bowel disease is associated with a low rate of recurrence

Donald K. Lei, Jacob E. Ollech, Michael Andersen, Roni Weisshof, Nada Zmeter, Philip Sossenheimer, David T. Rubin

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Long-duration oral vancomycin to treat clostridioides difficile in patients with inflammatory bowel disease is associated with a low rate of recurrence'. Together they form a unique fingerprint.

Medicine & Life Sciences